NOCIL Ltd Q1 FY26 Concall Decoded: Rubber, China, and Antidumping Drama
1. Opening Hook
Remember how Bollywood villains always sent 20 henchmen to beat one hero, but still lost? That’s NOCIL vs. Chinese dumping. Quarter looked flat, margins slipped, but the company’s pulling legal petitions like Sunny Deol pulling handpumps. The market, meanwhile, is playing wait-and-watch like Netflix buffering. Stick around—because by the end you’ll wonder if antidumping duties are NOCIL’s Rajnikanth moment.
2. At a Glance
Revenue: ₹336 Cr – Flat as your hostel’s Maggi in the morning.
EBITDA: ₹31 Cr – Down 9%, the sidekick tripped on its own shoelaces.
EBITDA Margin: 9.1% – From 14% last year; margin went on diet and lost muscle.
PAT: ₹17 Cr – 19% drop, profits ghosted like a Tinder date.
Exports: +3.5% – Not bad, but blamed U.S. tariffs like students blame power cuts.
Capex: ₹250 Cr project – 30% spent, but no revenue till FY27.
3. Management’s Key Commentary
MD V.S. Anand: “Revenue was ₹336 Cr, flat QoQ. Domestic market faced dumping pressure.” (Translation: China just dropped products cheaper than your chai-samosa combo. We’re surviving on exports.)
CFO P. Srinivasan: “EBITDA margins at 9.1% vs 10% last quarter.” (Translation: Margins are thinner than hostel mattress cotton.)
MD: “We filed antidumping petitions, government has started investigations.” (Translation: Bhai, ab asli picture shuru hogi—courtroom drama incoming.)
CFO: “Capex of ₹250 Cr is 30% spent, revenues from FY27 H2.” (Translation: Don’t expect popcorn before the interval.)
MD: “We’re working on 8 strategic levers—geography, innovation, efficiency, digitalization, people, etc.” (Translation: Basically every buzzword from Harvard Business Review stuffed into one PPT.)
MD: “Domestic share ~40%, exports growing, approvals ongoing in Asia, Europe, Americas.” (Translation: We’re on a world tour, but fans still prefer China’s remixes.)
